还原型谷胱甘肽对体外循环心脏瓣膜置换术患者炎性反应的影响  

Effects of glutathione on inflammatory response in patients undergoing cardiac valve replacement with cardiopulmonary bypass

在线阅读下载全文

作  者:郑国龙[1] 刘海林[1] 

机构地区:[1]南京医科大学附属淮安市第一人民医院麻醉科,江苏淮安223300

出  处:《中国新药与临床杂志》2014年第11期836-839,共4页Chinese Journal of New Drugs and Clinical Remedies

基  金:淮安市科技支撑计划(HAS2013034)

摘  要:目的评价还原型谷胱甘肽(GSH)对体外循环(CPB)心脏瓣膜置换术患者炎性反应的影响。方法择期CPB下行心脏瓣膜置换术患者60例,随机数字表法分为对照组和GSH组(均n=30)。两组麻醉诱导及维持方法相同,GSH组于麻醉诱导后静脉注射GSH 100mg·kg^-1,对照组加入等量的氯化钠注射液。于麻醉诱导后(T1)、CPB即刻(T2)、CPB结束(T3)、CPB结束2h(T4)和6h(T5)采取中心静脉血样,测定血浆心肌肌钙蛋白I(cTn I),肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-6、IL-1β和S100β蛋白的浓度。结果与T1时比较,T2~T5时两组血cTnI、TNF-α、IL-6、IL-1β和S100β蛋白的浓度均显著升高(P〈0.05);GSH组T2~T5时血cTnI、TNF-α、IL-6、IL-1β和S100β蛋白的浓度均显著低于对照组(P〈0.05)。结论CPB下心脏瓣膜置换术中GSH100mg·kg^-1可抑制炎性反应,从而减轻心、脑损伤。AIM To investigate the effects of glutathione (GSH) on inflammatory response in patients undergoing cardiac valve replacement with cardiopulmonary bypass. METHODS Sixty ASA physical status Ⅱ or m patients undergoing cardiac valve replacement with cardiopulmonary bypass (CPB), were randomly divided into two groups (n = 30 each) : control group and GSH group. Anesthesia induction and maintenance was same. A loading dose of glutathione 100 mg·kg^-1 was infused after anesthesia induction, while the equal volume of sodium chloride injection was infused in the control group. After induction (T1), before CPB (T2), after termination of CPB (T3), at 2 h after the end of CPB (T4) and at 6h after the end of CPB (T5) , blood samples were obstained from the jugular vein for determination of serum concentrations of cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-α), interleukin (IL) -6, IL-1β and S100β protein. RESULTS Compared with T1, serum cTnI, TNF-α, IL-6, IL-1β and S100β coneentrations were significantly increased at T2-T5. Compared with the eontrol group, serum cTnI, TNF-α, IL-6, IL-1β and S100β coneentrations were significantly deereased at T2-T5 in the glutathione group. CONCLUSION Glutathione can inhibit inflammtory response, thus reducing cardiae and cerebral injury in patients undergoing cardiac valve replacement with CPB.

关 键 词:谷胱甘肽 心肺转流术 炎症介导素类 心脏瓣膜疾病 

分 类 号:R614.2[医药卫生—麻醉学] R972.9[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象